Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells.

@article{Veldwijk2010PseudotypedRA,
  title={Pseudotyped recombinant adeno-associated viral vectors mediate efficient gene transfer into primary human CD34(+) peripheral blood progenitor cells.},
  author={Marlon Romano Veldwijk and Leopold Sellner and Marius Stiefelhagen and J{\"u}rgen A. Kleinschmidt and Stephanie Laufs and Julian Topaly and Stefan Fruehauf and Walter Jens Zeller and Frederik Wenz},
  journal={Cytotherapy},
  year={2010},
  volume={12 1},
  pages={
          107-12
        }
}
BACKGROUND AND AIMS Because of their pluripotency, human CD34(+) peripheral blood progenitor cells (PBPC) are targets of interest for the treatment of many acquired and inherited disorders using gene therapeutic approaches. Unfortunately, most current vector systems lack either sufficient transduction efficiency or an appropriate safety profile. Standard single-stranded recombinant adeno-associated virus 2 (AAV2)-based vectors offer an advantageous safety profile, yet lack the required… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-9 of 9 extracted citations

Radioprotective gene therapy.

Expert opinion on biological therapy • 2011
View 1 Excerpt

Similar Papers

Loading similar papers…